Business Intelligence Center

You are here: Home : White Papers : Accounting : Accounting Standards : Abstract

Accounting Considerations For The Life Science Industry

Sponsored By Burr Pilger Mayer

Topics:: Accounting > Accounting Standards , Tax; Banking & Capital Markets > Equity

View White Paper now

Free registration is required

Abstract:: The Life Science industry is growing rapidly, particularly in the San Francisco Bay Area. However, by its very nature,it faces unique and complex accounting challenges. Life Science companies must find ways to constantly refresh their financial strategies in order to bridge the gap between business and science.
This white paper discusses various strategies that Life Science companies employ in order to resolve some key areas with which they struggle:

- Private and public offerings can be structured using Private Investments in Public Equities (PIPEs). The warrants that arise must be valued.

- The primary rules for revenue recognition guidance are found in Staff Accounting Bulletins 101 and 104.

- Tax planning with an accountant is a vital step in navigating a complex tax environment full of potential risks and rewards.

DETAILS

Sponsored by: Burr Pilger Mayer

Released: March 23, 2010

Length: 7 pages

Format: PDF (3287 kb)

Email this abstract

These white papers are not created by the CFO.com editorial staff. In order to view these papers, you must register with CFO.com and agree to share your contact information with related product/service companies.